Chen WQ, Zheng RS, Baade PD, Zhang SW, Zeng HM, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
Article
PubMed
Google Scholar
Chen WQ, Zheng RS, Zeng HM, Zhang SW. The incidence and mortality of major cancers in China, 2012. Chin J Cancer. 2016;35(1):73.
Article
PubMed
PubMed Central
Google Scholar
Yang L, Yuan YN, Sun TT, Li HC, Wang N. Population-based cancer incidence analysis in Beijing, 2008–2012. Chin J Cancer Res. 2015;27(1):13–21.
PubMed
PubMed Central
Google Scholar
Li L, Ji J, Wang JB, Niyazi M, Qiao YL, Boffetta P. Attributable causes of breast cancer and ovarian cancer in China: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res. 2012;24(1):9–17.
Article
PubMed
PubMed Central
Google Scholar
Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol. 2014;15(5):489–538.
Article
PubMed
Google Scholar
Yang L, Sun TT, Wang N. The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(11):1009–14 (in Chinese).
PubMed
Google Scholar
Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003;106(3):416–22.
Article
CAS
PubMed
Google Scholar
Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, et al. Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer. 2013;132(5):1170–81.
Article
CAS
PubMed
Google Scholar
Prat A, Pineda E, Adamo B, Galvan P, Fernandez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(Suppl 2):S26–35.
Article
PubMed
Google Scholar
Cancer Genome Atlas. N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.
Article
Google Scholar
Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, et al. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol. 2009;100(2):89–94.
Article
PubMed
Google Scholar
Xue C, Wang X, Peng R, Shi Y, Qin T, Liu D, et al. Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China. Cancer Sci. 2012;103(9):1679–87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer. 2011;11:292.
Article
PubMed
PubMed Central
Google Scholar
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.
Article
PubMed
Google Scholar
Anderson WF, Rosenberg PS, Katki HA. Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer. J Natl Cancer Inst. 2014;106(5):dju093.
Article
PubMed
PubMed Central
Google Scholar
Zeng HM, Zheng RS, Guo YM, Zhang SW, Zou XN, Wang N, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer. 2015;136(8):1921–30.
Article
CAS
PubMed
Google Scholar
Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER Cancer Statistics Review, 1975–2014, National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/. Accessed 18 Apr 2017.
Australian Institute of Health and Welfare. Breast cancer in Australia. http://www.aihw.gov.au/cancer/breast/. Accessed 7 Mar 2017.
Hou Y, Chen XY. China health statistics yearbook of 2013. Beijing: People’s Medical Publishing House; 2014.
Google Scholar
Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer. 2013;108(5):1195–208.
Article
CAS
PubMed
PubMed Central
Google Scholar
DeSantis CE, Fedewa SA, Sauer AG, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42.
Article
PubMed
Google Scholar
Wang QJ, Zhu WX, Xing XM. Analysis of the incidence and survival of female breast cancer in Beijing during the last 20 years. Zhonghua Zhong Liu Za Zhi. 2006;28:208–10 (in Chinese).
PubMed
Google Scholar
Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134–50.
Article
PubMed
Google Scholar
Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, et al. A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer. 2011;11:364.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang BN. Thinking caused by the dispute of international breast cancer screening guidelines. Oncol Prog. 2016;14(2):109–11 (in Chinese).
Google Scholar
de Waard F, Kirkpatrick A, Perry NM, Tornberg S, Tubiana M, de Wolf C. Breast cancer screening in the framework of the Europe against Cancer programme. Eur J Cancer Prev. 1994;3(Suppl 1):3–5.
Article
PubMed
Google Scholar
US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26 (W-236).
Article
Google Scholar
Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force Recommendation. Ann Intern Med. 2016;164(4):244–55.
Article
PubMed
Google Scholar
Zulfiqar M, Rohazly I, Rahmah M. Do the majority of Malaysian women have dense breasts on mammogram? Biomed Imaging Interv J. 2011;7(2):e14.
PubMed
PubMed Central
Google Scholar
Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, et al. Supplemental screening for breast cancer in women with dense breasts: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2016;164(4):268–78.
Article
PubMed
PubMed Central
Google Scholar
Shen S, Zhou Y, Xu Y, Zhang B, Duan X, Huang R, et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer. 2015;112(6):998–1004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou HB, Liu SY, Lei L, Chen ZW, Peng J, Yang TZ, et al. Spatio-temporal analysis of female breast cancer incidence in Shenzhen, 2007–2012. Chin J Cancer. 2015;34(5):198–204.
PubMed
Google Scholar
O’Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16(24):6100–10.
Article
PubMed
PubMed Central
Google Scholar
Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33(20):2254–61.
Article
PubMed
PubMed Central
Google Scholar
Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol. 2004;51(1):55–67.
Article
PubMed
Google Scholar
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353(16):1659–72.
Article
CAS
PubMed
Google Scholar
Buzdar AU. Aromatase inhibitors: changing the face of endocrine therapy for breast cancer. Breast Dis. 2005;24:107–17.
Article
CAS
PubMed
Google Scholar
Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007;8(3):235–44.
Article
PubMed
Google Scholar
Yuan XM, Wang N, Ouyang T, Yang L, Song MY, Lin BY, et al. Current status of diagnosis and treatment of primary breast cancer in beijing, 2008. Chin J Cancer Res. 2011;23(1):38–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20(3):719–26.
Article
CAS
PubMed
Google Scholar
Holleczek B, Brenner H. Provision of breast cancer care and survival in Germany—results from a population-based high resolution study from Saarland. BMC Cancer. 2014;14:757.
Article
PubMed
PubMed Central
Google Scholar
Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89.
Article
PubMed
Google Scholar